Original ResearchEffects of Tilmicosin (cas 108050-54-0) Phosphate Administration on Echocardiographic Parameters in Healthy Donkeys (Equus asinus): An Experimental Study
-
Add time:08/29/2019 Source:sciencedirect.com
The aim of this study was to evaluate the effect of Tilmicosin (cas 108050-54-0) on echocardiographic measurements in donkeys. For this purpose, placebo and tilmicosin 30% (10 mg/kg) were administered subcutaneously to clinically healthy donkeys (n = 10) in a randomized prospective crossover study. Cardiac functions were evaluated by echocardiography using a 2.5-MHz curved-linear transducer at 0, 15, 30, 60, and 120 minutes after administration. Examination was carried out at 3 to 5 intercostal spaces, and measurements were obtained at three planes of images. Tilmicosin induced a significant decrease in fractional shortening percentage (FS%) at 30 minutes after treatment (P < .05), but ejection fraction percentage (EF%) and stroke volume (SV) were decreased at 60 minutes after treatment (P < .05). However, left ventricular volume at end-systole (LVESV) was increased when compared to placebo at 30, 60, and 90 minutes after administration (P < .05). Left ventricular volume at end-diastole (LVEDV) was increased at 60 minutes after treatment (P < .05). There was a positive correlation between FS% and EF% (r = 0.89, P < .01), LVESV and left ventricle internal diameter at systole (LVIDs; r = 0.97, P < .01), and SV and LVEDV (r = 0.56, P < .01). However, there was negative correlation between LVESV and EF% (r = −0.41, P < .05), ESV and FS% (r = −0.44, P < .05), LVIDs and EF% (r = −0.43, P < .05), and LVIDs and FS% (r = −0.47, P < .05). The present results indicate that tilmicosin could induce transient and short-lasting changes of cardiac function in donkeys.
We also recommend Trading Suppliers and Manufacturers of Tilmicosin (cas 108050-54-0). Pls Click Website Link as below: cas 108050-54-0 suppliers
Prev:Effects of nasal instillation of a nitric oxide-releasing solution or parenteral administration of Tilmicosin (cas 108050-54-0) on the nasopharyngeal microbiota of beef feedlot cattle at high-risk of developing respiratory tract disease
Next:Cholecystokinin (CCK) level is higher among first time suicide attempters than healthy controls, but is not associated with higher depression scores) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Effects of nasal instillation of a nitric oxide-releasing solution or parenteral administration of Tilmicosin (cas 108050-54-0) on the nasopharyngeal microbiota of beef feedlot cattle at high-risk of developing respiratory tract disease08/28/2019
- Astragalus polysaccharides alleviate Tilmicosin (cas 108050-54-0)-induced toxicity in rats by inhibiting oxidative damage and modulating the expressions of HSP70, NF-kB and Nrf2/HO-1 pathway08/27/2019
- ResearchEffects of oral Tilmicosin (cas 108050-54-0) on health and performance in newly received beef heifers08/26/2019
- Microstructure and antioxidative capacity of the microalgae mutant Chlorella PY-ZU1 during Tilmicosin (cas 108050-54-0) removal from wastewater under 15% CO208/25/2019
- Microbiological toxicity of Tilmicosin (cas 108050-54-0) on human colonic microflora in chemostats08/24/2019
- Minimum ignition energy of medicinal powder – Florfenicol and Tilmicosin (cas 108050-54-0)08/23/2019
- Preparation and evaluation of Tilmicosin (cas 108050-54-0) microspheres and lung-targeting studies in rabbits08/22/2019
- Removal of combined antibiotic (florfenicol, tylosin and Tilmicosin (cas 108050-54-0)) during anaerobic digestion and their relative effect08/21/2019